BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15449725)

  • 1. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline.
    Kovarik Z; Simeon-Rudolf V
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):113-7. PubMed ID: 15449725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparative HPLC separation of bambuterol enantiomers and stereoselective inhibition of human cholinesterases.
    Gazić I; Bosak A; Sinko G; Vinković V; Kovarik Z
    Anal Bioanal Chem; 2006 Aug; 385(8):1513-9. PubMed ID: 16865342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
    Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
    Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.
    Pistolozzi M; Du H; Wei H; Tan W
    Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
    Tunek A; Svensson LA
    Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase.
    Wu J; Tian Y; Wang S; Pistolozzi M; Jin Y; Zhou T; Roy G; Xu L; Tan W
    Eur J Med Chem; 2017 Jan; 126():61-71. PubMed ID: 27744187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
    Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
    Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine-Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors.
    Wu J; Tan Z; Pistolozzi M; Tan W
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
    Kovarik Z; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolysis of 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro.
    Tunek A; Levin E; Svensson LA
    Biochem Pharmacol; 1988 Oct; 37(20):3867-76. PubMed ID: 3190733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-inhibition relationships in the interaction of butyrylcholinesterase with bambuterol, haloxon and their leaving groups.
    Sinko G; Bosak A; Kovarik Z; Simeon-Rudolf V
    Chem Biol Interact; 2005 Dec; 157-158():421-3. PubMed ID: 16429568
    [No Abstract]   [Full Text] [Related]  

  • 14. Attenuated Total Reflectance Fourier Transformation Infrared spectroscopy fingerprinted online monitoring of the kinetics of circulating Butyrylcholinesterase enzyme during metabolism of bambuterol.
    Eid SM; Abd El-Rahman MK; Elghobashy MR; Kelani KM
    Anal Chim Acta; 2018 Apr; 1005():70-80. PubMed ID: 29389321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
    Bang U; Nyberg L; Rosenborg J; Viby-Mogensen J
    Br J Clin Pharmacol; 1998 May; 45(5):479-84. PubMed ID: 9643621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between bambuterol and physostigmine: aspects on cholinesterase inhibition and neuromuscular transmission in the smooth and skeletal muscles of the guinea-pig.
    Jeppsson AB; Waldeck B
    Pharmacol Toxicol; 1988 Oct; 63(4):211-4. PubMed ID: 2848230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa.
    Tunek A; Hjertberg E; Mogensen JV
    Biochem Pharmacol; 1991 Feb; 41(3):345-8. PubMed ID: 1994894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory survival mechanisms in acetylcholinesterase knockout mouse.
    Chatonnet F; Boudinot E; Chatonnet A; Taysse L; Daulon S; Champagnat J; Foutz AS
    Eur J Neurosci; 2003 Sep; 18(6):1419-27. PubMed ID: 14511322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of bambuterol (carbamylated terbutaline) on the duration of action of succinylcholine-induced paralysis in humans.
    Fisher DM; Caldwell JE; Sharma M; Wirén JE
    Anesthesiology; 1988 Nov; 69(5):757-9. PubMed ID: 3056118
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients.
    Bang U; Viby-Mogensen J; Wirén JE; Skovgaard LT
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):596-9. PubMed ID: 2244449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.